ACN Newswire Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
ACN Newswire Focus Graphite Engages Dr. Reuter Investor Relations to Expand German and European Capital Markets Presence
ACN Newswire CleverTap Recognized as a Leader in Latest Gartner Magic Quadrant for Personalization Engines
ACN Newswire The 18th Annual Global CSR & ESG Summit & Awards 2026 Arrives in Bangkok — Igniting Asia with AI, Energy & ESG Innovation on 23 April 2026
ACN Newswire Kincora and AngloGold Ashanti Exploration Expands and Upgrades Nevertire with Drilling Recommenced
ACN Newswire CTF Life+ Announces Winners of Financial Empowerment Case Competition, Innovative Platform Advances Intergenerational Inclusion
ACN Newswire Mint Signed MoU with Robotics Leader Rice Robotics to Pioneer Physical AI Solutions Across Asia
ACN Newswire Spritzer EcoPark Gallops into the Year of the Horse with a Tradition-Inspired Chinese New Year Celebration
ACN Newswire CITIC Telecom CPC Wins Two Awards, Celebrating ‘Innovation Never Stops’ for 25 Years, recognizing Cybersecurity & Innovation Excellence
ACN Newswire playX Secures Industry-Leading Player Protection Through Landmark Insurance Partnership with Great American Insurance Group
ACN Newswire Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc.
ACN Newswire GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China’s Core Innovative Drug Assets
ACN Newswire GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
ACN Newswire COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization
ACN Newswire Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors
ACN Newswire Muyuan Foods Makes Hong Kong Debut Today: Strong Cornerstone Investor Backing Fuels Rapid Earnings Growth, Embarking on New Journey of Internationalization
ACN Newswire Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
